Cel Sci Corporation (CVM)

[Phoenix2020]

Yesterday's daily short sale volume was 68.62% (as reported by FINRA) but despite all the manipulations by the shorts, the PPS went up 0.56%! The short borrow fee is still at 13.28%! With all the facts and clarifications that we got in the latest Letter to Shareholders and the news coming in from EMA, MHRA, Health Canada and FDA, it should just be a matter of time until Multikine will be approved and the heavy manipulation by the shorts will come to an end. To keep the PPS low, the shorts still have a position of currently 6.97 million shorted shares (short float of 13.34%). The CEO promises us an interesting month: "We are looking forward to a month filled with several very important meetings designed to bring our cancer therapy Multikine to market. We will keep you updated on our progress." I am so happy for all the cancer patients who will hopefully soon be able to profit from Multikine! GLTAL!!